Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Calcium Dobesilate × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Burkitt Lymphoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Smoldering Multiple Myeloma 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Down Syndrome 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Cytokine Release Syndrome 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Blast Crisis 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Cyclophosphamide 18 fludarabine 14 pembrolizumab 9 Etoposide 7 Dexamethasone 7 Rituximab 6 Gemcitabine 6 obinutuzumab 5 glofitamab 5 fludarabine phosphate 5 carfilzomib 4 Vincristine 4 Prednisone 4 Nivolumab 4 Carboplatin 4 zanubrutinib 3 ruxolitinib 3 pomalidomide 3 Paclitaxel 3 Lenalidomide 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Doxorubicin 3 venetoclax 2 tocilizumab 2 tisagenlecleucel 2 polatuzumab vedotin 2 ibrutinib 2 enzalutamide 2 duvelisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05552976 2026-04-01

SUCCESSOR-2

Bristol-Myers Squibb

Phase 3 Active not recruiting

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡